WellPoint, FDA Partner on Rx Drug Surveillance System
Indianapolis-based WellPoint is set to announce a partnership with FDA to use the insurer's database of 35 million members to scan for potentially harmful side effects of medications. The system is scheduled to launch next year. Other insurers also use their member databases to screen for side effects.
- "Insurers, FDA Team Up To Find Drug Problems" (Fuhrmans, Wall Street Journal, 4/15).